E2F7 & E2F8 in the control of transcription and cellular proliferation
E2F7 & E2F8 in the control of transcription and cellular proliferation
批准号:
7749926
负责人:
GUSTAVO Walter LEONE
金额:
$31.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-12-10 至 2012-11-30
关键词:
AblationAffinity ChromatographyAnimalsApoptosisBindingBiochemicalBiochemical GeneticsBiologicalCell CycleCell Cycle RegulationCell ProliferationCellsComplexDataDefectDevelopmentEmbryoFamilyFamily memberGene ExpressionGene TargetingGenerationsGenesGeneticGenetic TranscriptionHomoIndividualLaboratoriesMacromolecular ComplexesMalignant NeoplasmsMethodsMultiprotein ComplexesMusOncogenicPatternPhenotypePhosphotransferasesPlayPositioning AttributeProtein Sequence AnalysisProteinsReagentRecruitment ActivityResearchRoleSignal PathwayStructureSystemTechnologyTestingTissuesTranscription Repressor/CorepressorTumor Suppressor ProteinsWorkarmbasecombinatorialin vivomembernoveloverexpressionprogramspromoterprotein complexprotein protein interactiontranscription factor
中文摘要
描述(由申请人提供):E2F转录因子家族被认为在控制细胞增殖中起关键作用。这些因子由不同的基因编码,具有抑瘤和致癌功能(1-2)。我们的实验室确定E2F7和E2F8是该转录因子家族的最后两个成员(5,6)。本提案中提供的初步数据突出了这两个e2f的几个独特特征,这些特征将它们置于它们自己的子类中。这些显著特征包括它们形成同型二聚体和异源二聚体的能力,与大量的转录共抑制因子结合,沉默基因表达,阻断细胞增殖。虽然它们缺乏典型的Rb结合结构域,但E2F7可以特异性地与Rb相关蛋白相互作用,从而可以将E2F8招募到含Rb的复合物中。因此,E2F网络的E2F7/8臂仍然处于循环依赖性激酶(CDK)信号通路的控制之下。事实上,E2F7和E2F8具有相同的细胞周期依赖性和组织特异性表达模式,以及它们具有同源和异二聚体的能力,这提高了它们在动物中具有独特和共享功能的可能性。实验室多方面的努力已经取得了关键技术的发展,包括纯化E2F7/8相关蛋白的亲和纯化策略,鉴定靶基因的启动子阵列技术,以及在小鼠中破坏E2F7和E2F8的基因靶向方法。这些进展使我们的研究小组在对E2F家族这一重要分支如何控制细胞周期和细胞增殖的机制理解方面取得了重大进展。该建议的总体假设是E2F7和E2F8作为转录抑制因子负性控制细胞增殖。利用生化、生物物理、全局基因阵列和遗传方法的三个具体目标将直接检验这一假设:鉴定和表征E2F7-和e2f8 -相关的大分子蛋白复合物。具体目标2。鉴定E2F7和E2F8转录靶点。具体目标3。确定E2F7和E2F8在调控转录中的作用机制。这项工作将阐明这两个高度相关的家族成员对全面了解E2F转录活性的个体和组合贡献。
英文摘要
DESCRIPTION (provided by applicant): The E2F family of transcription factors is believed to play a critical role in the control of cellular proliferation. These factors are encoded by distinct genes and have both tumor suppressor and oncogenic functions (1-2). Our laboratory identified E2F7 and E2F8 as the final two members of this transcription factor family (5, 6). The preliminary data presented in this proposal highlight several unique features of these two E2Fs that place them in a subclass of their own. These salient features include their ability to form homodimers and heterodimers, to associate with a large cadre of transcriptional co-repressors, to silence gene expression, and to block cellular proliferation. While they lack a typical Rb-binding domain, E2F7 can specifically interact with Rb related proteins and can thus recruit E2F8 to Rb-containing complexes. As a result, the E2F7/8 arm of the E2F network remains under the control of the cycling dependent kinase (CDK) signaling pathway. The fact that E2F7 and E2F8 have an identical pattern of cell cycle dependent and tissue- specific expression, together with their ability to homo- and hetero-dimerize, raises the possibility that they may have both unique and shared functions in the animal. A multi-faceted effort in the laboratory has yielded key technical developments, including an affinity purification strategy to purify E2F7/8-associated proteins, promoter-array technologies to identify target genes, and gene targeting approaches to disrupt E2F7 and E2F8 in mice. These advances place our research group in a strong position to make significant advances towards a mechanistic understanding of how this important arm of the E2F family of factors controls the cell cycle and cell proliferation. The overarching hypothesis of this proposal is that E2F7 and E2F8 function as transcriptional repressors to negatively control cellular proliferation. Three specific aims utilizing biochemical, biophysical, global gene array, and genetic approaches will directly test this hypothesis: Specific Aim 1. To identify and characterize E2F7- and E2F8-associated macromolecular protein complexes. Specific Aim 2. To identify E2F7 and E2F8 transcriptional targets. Specific Aim 3. To determine the mechanism of E2F7 and E2F8 action in the control of transcription. This work will elucidate the individual and combinatorial contributions made by these two highly related family members towards the overall understanding of E2F transcriptional activity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tumor suppressor roles of E2F7 & E2F8 in hepatocellular carcinoma
-
批准号:9457804
-
项目类别:
-
资助金额:$27.12万
-
财政年份:2017
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
Leadership, Planning, and Evaluation
-
批准号:10589917
-
项目类别:
-
资助金额:$26.42万
-
财政年份:2009
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
Developmental Funds
-
批准号:10377477
-
项目类别:
-
资助金额:$58.11万
-
财政年份:2009
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
Leadership, Planning, and Evaluation
-
批准号:10377478
-
项目类别:
-
资助金额:$26.42万
-
财政年份:2009
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
Developmental Funds
-
批准号:10589916
-
项目类别:
-
资助金额:$58.11万
-
财政年份:2009
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
Medical University of South Carolina - Cancer Center Support Grant
-
批准号:9248275
-
项目类别:
-
资助金额:$209.3万
-
财政年份:2009
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
E2F7 & E2F8 in the control of transcription and cellular proliferation
-
批准号:8204520
-
项目类别:
-
资助金额:$30.19万
-
财政年份:2007
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
E2F7 & E2F8 in the control of transcription and cellular proliferation
-
批准号:7389747
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2007
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
Tumor Suppressor Roles of E2F7 & E2F8 in Hepatocellular Carcinoma (HCC)
-
批准号:8698044
-
项目类别:
-
资助金额:$34.62万
-
财政年份:2007
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
E2F7 & E2F8 in the control of transcription and cellular proliferation
-
批准号:7539216
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2007
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
E2F7 & E2F8 in the control of transcription and cellular proliferation
-
批准号:7995215
-
项目类别:
-
资助金额:$30.19万
-
财政年份:2007
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
E2F3 and embryonic development
-
批准号:7069571
-
项目类别:
-
资助金额:$32.41万
-
财政年份:2004
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
Suppression of Mammary Tumorigenesis by Stromal p53
-
批准号:9091438
-
项目类别:
-
资助金额:$29.92万
-
财政年份:2004
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
E2F3 and embryonic development
-
批准号:6858634
-
项目类别:
-
资助金额:$32.24万
-
财政年份:2004
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
E2F3 and embryonic development
-
批准号:6757647
-
项目类别:
-
资助金额:$33.19万
-
财政年份:2004
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
E2F3 and embryonic development
-
批准号:7232278
-
项目类别:
-
资助金额:$31.47万
-
财政年份:2004
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
Suppression of Mammary Tumorigenesis by Stromal p53
-
批准号:8678858
-
项目类别:
-
资助金额:$29.02万
-
财政年份:2004
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
Role of Rb and E2Fs in Regulating Stromal/Epithelial
-
批准号:6995150
-
项目类别:
-
资助金额:$20.4万
-
财政年份:2004
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
E2F3 and embryonic development
-
批准号:7410004
-
项目类别:
-
资助金额:$30.84万
-
财政年份:2004
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
Suppression of Mammary Tumorigenesis by Stromal p53
-
批准号:8246042
-
项目类别:
-
资助金额:$30.11万
-
财政年份:2004
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
海外基金